Pharmacogenetics of Breast Cancer

Towards the Individualization of Therapy
Herausgeber: Leyland-Jones, Brian

• Broschiertes Buch

Produktbeschreibung

Pharmacogenetics is becoming increasingly relevant in the diagnosis, treatment, and recovery of cancer patients. A major problem facing oncologists is the outstanding varied efficacy of treatment. Promising advances in pharmacogenetics have allowed the development of effective agents which will enable personalized cancer chemotherapy to become routine for the clinical practice.

---

Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.

Produktdetails

• Verlag: Taylor & Francis Ltd (Sales)
• Seitenzahl: 350
• Erscheinungstermin: 1. Mai 2008
• Englisch
• Abmessung: 229mm x 152mm x 19mm
• Gewicht: 472g
• ISBN-13: 9781420086379
• ISBN-10: 1420086375
• Artikelnr.: 23610932

Autorenporträt

Brian Leyland-Jones (Winship Cancer Institute, Emory University, Atlanta, Georgia) (Edited by)

Inhaltsangabe

Pharmacogenomic approaches. Individualized kinetics and dosing. Clasical
IHC and FISH state of the art. Affy-based chemo and dosing. Panoply of
genomic approaches. Epigenetics. Illumina-based platforms. Proteomics.
Measurement of Pharmacodynamic endpoints. What tissues are needed +
specimen collection